Insights+: COVID-19 Healthcare News Monthly Updates - November 2020

Share this

Insights+: COVID-19 Healthcare News Monthly Updates - November 2020

  • Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
  • Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease
  • PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date

1. Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

Nov 29, 2020 | Collaboration

2. Colchicine Shows Promise as a Treatment for At-Home COVID-19 Patients -- Recruitment of Participants in the COLCORONA P-III Study Likely to End in 2020

Nov 28, 2020 | Clinical Trial

3. BASE10 and DNA Link Partners on Research to Support Authorization of Antibody Test at the Point of Care

Nov 26, 2020 | Clinical Trial

4. Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

Nov 25, 2020 | Regulatory

5. Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies 

Nov 25, 2020 | Regulatory 

6. CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients 

Nov 25, 2020 | Clinical Trial 

7. NeuroRx and Relief Announce Initial Successful Rsults from Expanded Access Use of RLF-100 (aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients 

Nov 24, 2020 | Clinical Trial 

8. Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens 

Nov 24, 2020 | Grant 

9. ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years 

Nov 24, 2020 | Clinical Trial 

10. Longitude Prize Launches AMR Voices: Stories from the frontlines of antibiotic resistance during Covid-19 

Nov 24, 2020 | Launch 

11. Arizona BioTech Company Successfully Completes Pre-Clinical Testing for Vaccine Alternative to Prevent COVID-19 Infection, Ready for Human Trials 

Nov 23, 2020 | Clinical Trial 

12. FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 

Nov 21, 2020 | Regulatory 

13. Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization 

Nov 21, 2020 | Regulatory 

14. Lilly's Neutralizing Antibody bBmlanivimab (LY-CoV555) Receives Interim Authorization from Health Canada as a Treatment for COVID-19 

Nov 20, 2020 | Regulatory 

15. Persavita is Preparing for a Clinical Trial to Test its Experimental Natural Health Product in Covid-19 

Nov 20, 2020 | Clinical Trial 

16. FDA Grants Emergency Use Authorisation for Baricitinib in Hospitalised COVID-19 Patients Nine Months After Initial Hypothesis was Published by BenevolentAI 

Nov 20, 2020 | Regulatory 

17. Sosei Heptares' COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development 

Nov 20, 2020 | Clinical Trial 

18. Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19 

Nov 19, 2020 | Regulatory 

19. Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim Collaborate on First Study to Evaluate Nintedanib in Patients with Fibrosing ILD following COVID-19 Infection 

Nov 19, 2020 | Collaboration 

20. RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib 

Nov 19, 2020 | Regulatory 

21. India's Indigenous Solution to COVID-19 in Progress 

Nov 19, 2020 |  Pharma

22. In the lab, St. Jude Scientists Identify Possible COVID-19 Treatment 

Nov 18, 2020 |  Pharma

23. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers 

Nov 18, 2020 | Collaboration 

24. BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections 

Nov 18, 2020 | Clinical Trial 

25. Diabetes, Hypertension May Increase Risk of COVID-19 Brain Complications 

Nov 18, 2020 |  Pharma

26. FDA Authorizes First COVID-19 Test for Self-Testing at Home 

Nov 17, 2020 | Diagnostic 

27. Ampio's Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress 

Nov 17, 2020 | Clinical Trial 

28. RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease 

Nov 17, 2020 | Clinical Trial 

29. Samsung Biologics Announces Strategic Manufacturing Partnership with Lilly to Accelerate Delivery of COVID-19 Antibody Treatments 

Nov 17, 2020 | Collaboration 

30. TrippBio Reports Positive Results from Investigator-Initiated Clinical Trial of TD213 for the Treatment of Mild to Moderate COVID-19 Infections 

Nov 16, 2020 | Clinical Trial 

31. RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks 

Nov 16, 2020 | Clinical Trial 

32. INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense 

Nov 16, 2020 | Clinical Trial 

33. Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate 

Nov 16, 2020 | Clinical Trial 

34Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development 

Nov 14, 2020 | Collaboration 

35. NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100 for Critical COVID-19 with Respiratory Failure 

Nov 13, 2020 | Clinical Trial 

36. Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate 

Nov 12, 2020 | Clinical Trial 

37. AstraZeneca Partners with CCT to Conduct COVID-19 Vaccine Clinical Trials in Arizona 

Nov 12, 2020 | Collaboration 

38. Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies 

Nov 11, 2020 | Collaboration 

39. NYU Langone Health to Enroll Healthy Volunteers In Clinical Trial for COVID-19 Vaccine 

Nov 11, 2020 | Clinical Trial 

40. ADVAITE's High Complexity CLIA Lab Receives Authorization from Yale University to Offer Highly Accurate COVID-19 SalivaDirect™ Test 

Nov 11, 2020 | Regulatory 

41. Sagent Pharmaceuticals Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 Treatment 

Nov 11, 2020 | Clinical Trial 

42. Mountain Valley MD Files Patent to Protect Science Achievement in Solubilization of ivermectin Without Organic Solvents and Its Application to COVID-19 and Other Therapies 

Nov 11, 2020 | Regulatory 

43. The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy 

Nov 11, 2020 | Clinical Trial 

44. Co-Diagnostics Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction 

Nov 11, 2020 |  Clinical Trial 

45. Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress 

Nov 10, 2020 | Clinical Trial 

46. CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients 

Nov 10, 2020 |  Clinical Trial 

47. New Research Published in The Lancet Psychiatry Finds COVID-19 Associated with Increased Risk for Developing Psychiatric Disorders 

Nov 9, 2020 |  Clinical Trial

48. New COVID Vaccine Clinical Trials Enrolling At Local Lake Charles Research Site 

Nov 9, 2020 | Clinical Trial 

49. CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients 

Nov 6, 2020 | Clinical Trial 

50. NeuroRx and Relief Therapeutics Announce Continuation of RLF-100 trial for Treatment of COVID-19 Respiratory Failure: Trial is on Track to Complete Enrollment in 2020 

Nov 5, 2020 | Clinical Trial 

51. New Research Study Validates Performance and Accuracy of Truvian Sciences' Easy Check COVID-19 IgM/IgG Test 

Nov 3, 2020 | Regulatory 

52. Senhwa Announces Multiple IND application submissions to US FDA for Silmitasertib as a Potential Treatment for COVID-19 

Nov 2, 2020 | Regulatory 

53. Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine 

Nov 2, 2020 |  Clinical Trial 

54. RevImmune Advances New Immunotherapy in COVID-19 

Nov 2, 2020 |  Clinical Trial 

55. Immunic, Inc. Announces 200 Patients Enrolled in Its Phase 2 CALVID-1 Trial of IMU-838 for the Treatment of Moderate COVID-19, Allowing for Main Phase 2 Efficacy Analysis to Proceed 

Nov 2, 2020 | Clinical Trial 

Related Post: Insights+: COVID-19 Healthcare News Monthly Updates  October 2020

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions